View of A Cost-Effectiveness Study of Sequential Therapy Using Levofloxacin Versus Cefuroxime in the Treatment of Moderate Risk Community-Acquired Pneumonia (ATS III) in Adults

Return to Article Details A Cost-Effectiveness Study of Sequential Therapy Using Levofloxacin Versus Cefuroxime in the Treatment of Moderate Risk Community-Acquired Pneumonia (ATS III) in Adults Download Download PDF